Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-05-22 12:45:45
- Reporting Period:
- 2009-05-22
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376099 | Jack Kaye | 750 Lexington Avenue New York NY 10022 | Yes | No | No | No |
Transaction Summary
| Purchased: | 35,000 shares | Avg. Price: $0.43 | Total Value: $15,015.00 |
| Number of Shares After Transactions: | 96,400 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2009-05-22 | 35,000 | $0.43 | 96,400 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
